Market
Eli Lilly Global Manufacturing Investment Total by End of 2026?
3
Resolution / Starting Odds
Less than $25 billion • 25%
$25 billion to $30 billion • 25%
$30 billion to $35 billion • 25%
More than $35 billion • 25%
Eli Lilly's financial reports or official statements
Story
Eli Lilly Boosts Wisconsin Plant with $3B Investment, Adding 750 Jobs
Dec 5, 2024, 08:33 PM
Eli Lilly and Co. has announced a significant investment of $3 billion to expand its manufacturing facility in Pleasant Prairie, Wisconsin. The expansion aims to increase production capacity for diabetes and obesity medicines, responding to the soaring demand for these treatments. This move is part of a broader $23 billion investment in global manufacturing since 2020. The expansion is expected to create 750 new jobs and will benefit millions of patients globally by enhancing the supply of Lilly's weight-loss and diabetes drugs.
View original story
Similar markets
Stock price increases by less than 5% • 25%
Stock price increases by 10% to 15% • 25%
Stock price increases by 5% to 10% • 25%
Stock price increases by more than 15% • 25%
3-4 new partnerships • 25%
5 or more new partnerships • 25%
0 new partnerships • 25%
1-2 new partnerships • 25%
$1 billion to $2 billion • 25%
Less than $1 billion • 25%
$2 billion to $3 billion • 25%
More than $3 billion • 25%
Less than $250 million • 25%
More than $1 billion • 25%
$500 million to $1 billion • 25%
$250 million to $500 million • 25%
Other • 25%
Europe • 25%
North America • 25%
Asia • 25%
AI in Drug Discovery • 25%
Genomics • 25%
Digital Health • 25%
Other • 25%